Fibrotech

Fibrotech Therapeutics develops and provides new drugs for the treatment of chronic fibrosis, which is beneficial for the development of drugs to treat kidney disease, diabetes, heart failure, pulmonary fibrosis, and arthritis. The company was founded in 2006, and Fibrotech Therapeutics is headquartered in Wonga Park, Australia.